(c) When multiple fragile primary receptacles are placed in a single secondary packaging, they are either individually wrapped or separated to prevent contact between them.
NOTE 1: An element of professional judgment is required to determine if a substance is exempt under this paragraph. That judgment should be based on the known medical history, symptoms and individual circumstances of the source, human or animal, and endemic local conditions.
Examples of specimens which may be carried under this paragraph include:
- the blood or urine tests to monitor cholesterol levels, blood glucose levels, hormone levels, or prostate specific antibodies (PSA);
- those required to monitor organ function such as heart, liver or kidney function for humans or animals with non-infectious diseases, or for therapeutic drug monitoring;
- those conducted for insurance or employment purposes and are intended to determine the presence of drugs or alcohol;
- pregnancy test;
- biopsies to detect cancer;
-antibody detection in humans or animals in the absence of any concern for infection (e.g. evaluation of vaccine induced immunity, diagnosis of autoimmune disease,etc.).
NOTA 2: For air transport, packagings for specimens exempted under this paragraph shall meet the conditions in (a) to (c).
2.2.62.1.5.7 Except for:
(a) Medical waste (UN No. 3291);
(b) Medical devices or equipment contaminated with or containing infectious substances in Category A (UN No. 2814 or UN No. 2900);
(c) Medical devices or equipment contaminated with or containing other dangerous goods that meet the definition of another class